Drug Safety

Aims & Scope

Drug Safety is the official journal of the International Society of Pharmacovigilance.

The journal includes: Overviews of contentious or emerging issues.

Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes.

In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area.

Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics.

Editorials and commentaries on topical issues.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content.

In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.8
2024	4.00

Journal Rank

Year	Value
2024	3963

Journal Citation Indicator

Year	Value
2024	1223

SJR (SCImago Journal Rank)

Year	Value
2024	1.127

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	146

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Under-Reporting of Adverse Drug Reactions

  Citation: 1350

  Authors: Lorna, Saad A W

• The Medical Dictionary for Regulatory Activities (MedDRA)

  Citation: 966

  Authors: Elliot G., Louise, Sue

• Cardiotoxicity of Chemotherapeutic Agents

  Citation: 573

  Authors: Vinita B., Milap C.

• Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database

  Citation: 548

  Authors: Ana, Stella G., Robert T.

• Determinants of Under-Reporting of Adverse Drug Reactions

  Citation: 421

  Authors: Elena, Maria T., Adolfo

• Drug-Induced Liver Injury Network (DILIN) Prospective Study

  Citation: 413

  Authors: Robert J., Paul B., Herbert L., Naga, Timothy, Jose, James

• Drug-Related Problems in Hospitals

  Citation: 390

  Authors: Anita, Raymond, Markus, Manuel, J??rgen, Stephan

• Antimalarial Drug Toxicity

  Citation: 359

  Authors: W Robert J, Nicholas J

• Orlistat-Associated Adverse Effects and Drug Interactions

  Citation: 337

  Authors: Theodosios D, Christos S, Irene F, Eleni S, Dimitri P, Moses S

• Causes of Medication Administration Errors in Hospitals: a Systematic Review of Quantitative and Qualitative Evidence

  Citation: 332

  Authors: Richard N., Steven D., Jonathan, Darren M.

---